KAYLA WILLIAMS: Open Payments
NPI 1447715024 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 9 payments from 6 companies in 2025. Trend: 2023 $127 · 2024 $16 · 2025 $394
Food & beverage: $301Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $136 |
| Eisai Inc. | 1 | $119 |
| GENZYME CORPORATION | 2 | $56 |
| Amgen Inc. | 1 | $43 |
| Lundbeck LLC | 1 | $24 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: Leqembi, IMBRUVICA, EPKINLY, REPATHA, VYEPTI, SARCLISA, ERLEADA.
Industry payments across AR — which companies pay providers there.
